NCT00140647View on ClinicalTrials.gov

The Study of Atherosclerosis With Ramipril and Rosiglitazone

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

July 31, 2001

Study Completion Date

July 31, 2006

Conditions
AtherosclerosisImpaired Glucose ToleranceIsolated Impaired Fasting GlucoseCardiovascular Disease
Interventions
DRUG

Ramipril

DRUG

Rosiglitazone

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Ontario

OTHER

lead

Gerstein, Hertzel, MD

INDIV

NCT00140647 - The Study of Atherosclerosis With Ramipril and Rosiglitazone | Biotech Hunter | Biotech Hunter